drugset / Trial / NCT01252680

Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines

NCT01252680

Phase 4 Completed 303 enrolled Sinovac Biotech Co., Ltd
RandomizedCrossoverTriple-blindPrevention

Summary

This is a randomized, double-blind clinical trial of two inactivated hepatitis A vaccines in healthy children, immunogenicity and interchangeability of the two inactivated hepatitis A vaccines were evaluated.

Timeline

Start
2010-04
Primary completion
2011-02
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Havrix Vaccine 720 unknown Intramuscular
Subject Healive Vaccine 250 iu Intramuscular